Sign inGet started

Morgenthaler Management Partners VII, LLC

Insider CIK 1379550 · GBIM 10% owner · OMED 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-09116,586$1.45 $169.0K0SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-092,528,000— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-095,904,335— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-093,879,015— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-09259,235— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-09162,369$1.34 $217.6K0SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-095,172— $05,172SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-093,714— $03,714SEC↗
GBIM GLOBEIMMUNE INC P Buy2014-07-082014-07-09130,000$10.00 $1.30M530,461SEC↗
GBIM GLOBEIMMUNE INC C Conversion2014-07-082014-07-09400,461— $0400,461SEC↗
OMED OncoMed Pharmaceuticals In C Conversion deriv2013-07-232013-07-23893,825— $00SEC↗
OMED OncoMed Pharmaceuticals In C Conversion deriv2013-07-232013-07-23710,526— $00SEC↗
OMED OncoMed Pharmaceuticals In C Conversion deriv2013-07-232013-07-23834,732— $00SEC↗
OMED OncoMed Pharmaceuticals In C Conversion2013-07-232013-07-23834,732— $01,545,258SEC↗
OMED OncoMed Pharmaceuticals In C Conversion2013-07-232013-07-23893,825— $02,439,083SEC↗
OMED OncoMed Pharmaceuticals In P Buy2013-07-232013-07-2370,588$17.00 $1.20M2,509,671SEC↗
OMED OncoMed Pharmaceuticals In C Conversion2013-07-232013-07-23710,526— $0710,526SEC↗